Peripheral Intravenous Catheters PIVC Sales

Peripheral Intravenous Catheters PIVC Sales Market Outlook

The global Peripheral Intravenous Catheters (PIVC) market is projected to reach a valuation of approximately USD 8.4 billion by 2035, growing at a compound annual growth rate (CAGR) of around 6.5% during the forecast period of 2025 to 2035. This growth can be attributed to the increasing prevalence of chronic diseases, the rise in surgical procedures, and advancements in catheter technology which enhance patient safety and comfort. Additionally, the aging population worldwide is leading to greater demand for healthcare services, thereby boosting the need for effective intravenous therapies. The shift towards outpatient care and home healthcare settings is also facilitating the market growth as healthcare providers seek to minimize hospital stays and costs.

Growth Factor of the Market

The Peripheral Intravenous Catheters (PIVC) market is experiencing significant growth due to several key factors. Firstly, the rising incidence of chronic diseases such as diabetes and cancer necessitates frequent intravenous access for medication and fluid administration, which is driving demand for PIVCs. Secondly, the expansion of healthcare facilities, especially in developing regions, is enhancing the accessibility and usage of intravenous therapies. Moreover, technological advancements in catheter design, such as the development of integrated PIVCs that reduce the risk of complications, are attracting healthcare providers to adopt these innovative solutions. The growing emphasis on patient safety and infection control practices within healthcare environments is another critical growth driver, as healthcare institutions are increasingly focused on using devices that minimize the risk of catheter-related bloodstream infections. Furthermore, an increase in outpatient and home healthcare services has resulted in a higher demand for portable and easy-to-use intravenous systems, further propelling the market forward.

Key Highlights of the Market

• The global PIVC market is projected to register a CAGR of 6.5% from 2025 to 2035.
• Technological advancements in catheter design are enhancing safety and reducing complications.
• The rise in chronic disease prevalence is a significant demand driver for PIVCs.
• Increasing adoption of outpatient care and home healthcare settings is reshaping market dynamics.
• Regional growth is notably strong in North America and Asia Pacific, contributing significantly to market share.

By Product Type

Short PIVC:

Short Peripheral Intravenous Catheters (PIVCs) are extensively used across healthcare settings for short-term intravenous access, particularly in administering medication, fluids, and blood products. They typically range from 1 to 4 inches in length and are designed for rapid insertion, making them ideal for emergency situations or short hospital stays. Their convenience, coupled with the ability to access peripheral veins quickly, propels their demand in hospitals and clinics, especially for acute care settings. The development of various gauge sizes also allows healthcare professionals to select a suitable catheter for different patient needs, such as pediatric or geriatric populations, which enhances their versatility and application in diverse clinical scenarios.

Integrated PIVC:

Integrated PIVCs are designed to incorporate features that reduce the risk of complications and improve patient safety. These catheters often include safety mechanisms such as retractable needles or integrated valve systems that minimize exposure to blood and reduce the likelihood of needlestick injuries. The increasing awareness of infection control practices and regulations is driving the adoption of integrated PIVCs among healthcare professionals. These devices are particularly favored in surgical and critical care environments where the risk of infection is heightened. Additionally, the trend towards minimizing hospital-acquired infections has made integrated PIVCs a preferred choice, thus contributing positively to their market growth.

Non-integrated PIVC:

Non-integrated PIVCs are traditional catheters that do not include built-in safety features. While they remain widely used due to their cost-effectiveness, they are often associated with higher risks of complications, such as catheter-related infections. Despite these challenges, non-integrated PIVCs hold a significant share of the market, particularly in settings where budget constraints are prevalent. Their widespread availability and established protocols for usage allow for their continued relevance in the marketplace, even as integrated solutions gain popularity. The ongoing development of guidelines aimed at minimizing risks associated with non-integrated PIVCs is vital for maintaining their usability in various healthcare settings.

Winged PIVC:

Winged PIVCs, often known as butterfly needles, are characterized by their 'wings' that provide easier handling during insertion. They are primarily utilized for short-term venous access and are particularly beneficial in pediatric or geriatric populations where vein accessibility can be a challenge. The ease of use and flexibility offered by winged PIVCs make them valuable in outpatient settings, blood draws, and for infusions that require rapid administration. Their design allows for greater stability during the procedure, which can enhance patient comfort and minimize movement-related complications. The preference for winged PIVCs in specific applications ensures a steady demand in the marketplace.

Ported PIVC:

Ported PIVCs are designed for patients who require long-term venous access, facilitating repeated access with minimal discomfort. These catheters are often used in oncology settings for chemotherapy administration or in patients requiring long-term medication infusions. Their unique design allows for access to the bloodstream with reduced risk of infection and better patient compliance. With the increasing emphasis on outpatient care, ported PIVCs are gaining traction as they provide a practical solution for managing long-term intravenous therapy without the need for continuous hospitalization. This segment's growth is bolstered by the rising incidence of chronic diseases necessitating prolonged treatment regimens.

By Application

Hospitals:

Hospitals represent one of the largest application segments for Peripheral Intravenous Catheters (PIVCs), as they are critical for administering medications, fluids, and blood products quickly and efficiently. In hospital settings, PIVCs are utilized in various departments, including emergency care, surgery, and oncology, where timely intervention is essential. The rising number of surgeries and emergency admissions due to chronic illnesses has significantly increased the demand for PIVCs in hospitals. Furthermore, hospitals are adopting newer technologies and improved safety protocols, driving the use of advanced PIVCs, particularly integrated models that help reduce the risk of complications. As hospitals prioritize patient safety and effective care delivery, the demand for PIVCs is expected to grow steadily in this segment.

Clinics:

Clinics are increasingly adopting Peripheral Intravenous Catheters (PIVCs) to offer enhanced patient care. With a focus on outpatient services, clinics require efficient methods for administering treatments, such as intravenous hydration or medication infusions. PIVCs facilitate quick access to the bloodstream, allowing healthcare providers to deliver care in a timely manner without requiring patients to visit emergency rooms or hospitals. This trend is particularly relevant in specialty clinics, such as those focusing on chronic disease management, where frequent intravenous access is necessary. The growing trend towards healthcare consumerism, where patients prefer to receive care in more accessible settings, is further driving the adoption of PIVCs in clinics.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are increasingly relying on Peripheral Intravenous Catheters (PIVCs) to provide safe and efficient care for outpatient surgical procedures. With the rise of same-day discharge practices, the demand for rapid and effective intravenous access is critical in these settings. PIVCs allow for the administration of sedation, fluid management, and medications during surgeries, which enhances the overall experience for patients undergoing outpatient procedures. The convenience and efficiency of PIVCs align well with the operational model of ASCs, which focus on minimizing patient wait times and maximizing throughput. As ASCs continue to grow in popularity, the demand for PIVCs is likely to expand correspondingly.

Homecare Settings:

Homecare settings are emerging as a significant application area for Peripheral Intravenous Catheters (PIVCs) due to the increasing shift towards home-based healthcare solutions. Patients requiring long-term intravenous therapy, such as those undergoing chemotherapy or long-term antibiotic treatment, can benefit from the use of PIVCs in their homes. This approach not only enhances patient comfort but also reduces healthcare costs associated with hospitalization. The trend toward managing chronic conditions at home, combined with advancements in catheter technology that make them easier and safer to use, is driving the adoption of PIVCs in homecare. This segment is expected to witness robust growth as more patients and healthcare providers embrace the homecare model.

Others:

The 'Others' application segment for Peripheral Intravenous Catheters (PIVCs) encompasses various settings and specialized uses not covered by the primary categories. This includes applications in research laboratories, veterinary clinics, and emergency services, where quick and efficient intravenous access may be required. Additionally, PIVCs are used in specialty areas like palliative care, where managing symptoms effectively is crucial. The versatility of PIVCs allows them to be utilized across a range of healthcare contexts, contributing to the overall growth of the market. As healthcare evolves and new treatment modalities emerge, the potential applications for PIVCs will likely expand further, introducing new opportunities for market players.

By Distribution Channel

Direct Sales:

Direct sales channels play a vital role in the distribution of Peripheral Intravenous Catheters (PIVCs), allowing manufacturers to build strong relationships with healthcare providers while ensuring that their products meet specific needs. This approach enables manufacturers to offer customized solutions and respond quickly to changes in demand. Direct sales also facilitate better education and training for healthcare professionals on the usage and benefits of specific PIVC products. This channel is particularly effective for companies that specialize in high-quality, technologically advanced PIVCs. The growth of direct sales is supported by an increased focus on personalized customer service and the growing importance of maintaining strong supplier relationships in the healthcare industry.

Distributor Sales:

Distributor sales channels are also critical for the Peripheral Intravenous Catheters (PIVCs) market, as they provide widespread access to a diverse range of products across numerous healthcare settings. Distributors typically have established networks and can efficiently manage logistics and inventory, allowing hospitals and clinics to maintain consistent stock levels without the burden of direct procurement. This channel is particularly beneficial for smaller healthcare facilities that may not have the resources to negotiate directly with manufacturers. With the increasing complexity of healthcare supply chains, distributor sales are becoming increasingly important, facilitating the distribution of both conventional and advanced PIVC solutions to broader markets.

By Material Type

Polyurethane PIVC:

Polyurethane PIVCs have gained significant popularity due to their biocompatibility, flexibility, and durability. These catheters exhibit lower friction and better flow rates compared to traditional materials, which enhances patient comfort during insertion and use. Polyurethane also has a high tensile strength, making these catheters resistant to kinking and breaking, which is critical for maintaining stable intravenous access. Additionally, the material's clarity allows for better visibility of the catheter, enabling healthcare professionals to monitor the site easily. As patient safety and comfort are paramount in healthcare, the demand for polyurethane PIVCs is expected to continue to rise.

Teflon PIVC:

Teflon PIVCs are characterized by their smooth surface, which reduces the risk of thrombosis and improves overall flow rates. The material is known for its strength and resistance to chemical exposure, making it suitable for various intravenous applications. Teflon catheters are particularly favored for short-term use in acute care settings, where rapid access is essential. While Teflon PIVCs are less flexible than polyurethane versions, their reliability and ease of insertion contribute to their sustained demand in the market. The established protocols for Teflon catheters in healthcare settings ensure their continued relevance, particularly in environments that prioritize rapid intravenous access.

Polyethylene PIVC:

Polyethylene PIVCs are commonly used due to their cost-effectiveness and availability. While they may not offer the same level of performance as polyurethane or Teflon catheters, polyethylene PIVCs are still a popular choice for many healthcare facilities due to their ease of use and low procurement costs. They are particularly suitable for short-term applications where budget constraints are a consideration. The simplicity of polyethylene catheters makes them accessible for a wide range of healthcare settings, reinforcing their market share. However, advancements in materials may challenge their dominance as newer solutions that prioritize patient safety and comfort gain traction.

FEP PIVC:

Fluorinated ethylene propylene (FEP) PIVCs are known for their excellent chemical resistance and biocompatibility. These catheters are often used in specialized applications, such as in patients requiring long-term intravenous therapy. The unique properties of FEP prevent binding and thrombus formation, ensuring that the catheter remains patent for extended periods. Additionally, FEP PIVCs are less likely to cause allergic reactions, making them suitable for patients with sensitivities to other materials. The increasing recognition of the importance of long-term access solutions in chronic disease management is propelling the demand for FEP PIVCs, particularly in outpatient settings.

Others:

The 'Others' category encompasses various niche materials used in the manufacturing of Peripheral Intravenous Catheters (PIVCs). These may include innovative materials and composites designed to enhance performance and safety. Manufacturers are continually exploring new materials that can offer improved properties, such as antimicrobial coatings or bioengineered solutions that promote healing and reduce infection rates. As the healthcare industry evolves, the demand for specialized PIVCs made from these alternative materials is expected to increase, driven by the need for enhanced patient outcomes and safety. This segment also presents opportunities for manufacturers to differentiate their products and cater to specific market demands.

By Region

The North American region holds a dominant position in the Peripheral Intravenous Catheters (PIVC) market, accounting for approximately 40% of the global share. The region benefits from a well-established healthcare infrastructure, high healthcare expenditure, and a growing emphasis on patient safety and infection control. With the increasing prevalence of chronic diseases and a rising number of surgical procedures, the demand for PIVCs is expected to grow at a CAGR of 5.8% from 2025 to 2035. The United States is the primary contributor to this growth, driven by advanced healthcare facilities and a focus on innovative medical technologies.

In contrast, the Asia Pacific region is anticipated to witness the highest growth rate in the PIVC market, with a projected CAGR of 7.5% during the forecast period. The increasing population, urbanization, and rising incidence of chronic diseases are key factors contributing to this growth. Countries like China and India are investing in the expansion of their healthcare systems, which includes upgrading medical facilities and increasing access to intravenous therapies. As more healthcare providers adopt advanced PIVC technologies, the Asia Pacific region is positioning itself as a vital market for the future.

Opportunities

The Peripheral Intravenous Catheters (PIVC) market is ripe with opportunities driven by advancements in technology and the evolving healthcare landscape. One significant opportunity lies in the development of smart PIVCs integrated with sensors and monitoring systems. These innovations can provide real-time data on catheter status, helping healthcare providers to detect complications early and enhance patient safety. As the healthcare industry adopts more connected devices, the potential for smart PIVCs will likely grow, providing manufacturers with a competitive edge. Additionally, as telemedicine becomes more prevalent, the demand for homecare solutions, including portable PIVCs, is expected to increase, enabling patients to receive intravenous therapies safely and effectively in their homes.

Another opportunity for market growth is the rising focus on infection prevention and control within healthcare facilities. As hospitals and clinics strive to reduce hospital-acquired infections, the adoption of advanced PIVCs designed with antimicrobial properties or safety features will become increasingly important. This trend presents a chance for manufacturers to innovate and differentiate their products to meet the growing demand for safer intravenous solutions. Furthermore, the expansion of healthcare services in developing regions provides a lucrative market for PIVCs, as the need for reliable intravenous access in hospitals and clinics is paramount. By addressing the unique needs of these emerging markets, companies can tap into a new customer base and drive significant revenue growth.

Threats

Despite the positive outlook for the Peripheral Intravenous Catheters (PIVC) market, there are certain threats that could impede growth. One of the primary challenges facing the market is the increasing competition from alternative intravenous access methods, such as midline catheters and peripherally inserted central catheters (PICCs). These alternatives offer advantages in terms of prolonged access and reduced risk of complications, potentially diverting demand away from traditional PIVCs. Additionally, the growing emphasis on cost-cutting measures within healthcare systems may lead to a preference for lower-cost solutions, which could impact the sales of high-quality, technologically advanced PIVCs. Manufacturers must remain vigilant and adapt their strategies to stay competitive in an evolving market landscape.

Another significant restrainer for the PIVC market is the potential for regulatory challenges and scrutiny surrounding the safety and efficacy of medical devices. As healthcare regulations become more stringent, manufacturers may face increased compliance costs and extended timelines for product approvals. Any potential recalls or safety concerns related to PIVCs could adversely affect consumer trust and brand reputation. Additionally, the ongoing global supply chain disruptions experienced in recent years could lead to delays in product availability, impacting market growth. Companies must prioritize quality assurance and compliance to navigate these challenges effectively.

Competitor Outlook

• Becton, Dickinson and Company
• Smiths Medical
• Vygon S.A.
• Teleflex Incorporated
• Terumo Corporation
• Fresenius Kabi AG
• Medtronic plc
• 3M Company
• Nipro Medical Corporation
• Cook Medical Incorporated
• AngioDynamics, Inc.
• Halyard Health, Inc.
• Cardinal Health, Inc.
• C.R. Bard, Inc.
• Ruhof Healthcare, Inc.

The competitive landscape of the Peripheral Intravenous Catheters (PIVC) market is characterized by a mix of established players and emerging manufacturers, each striving to differentiate their products through innovation and technological advancements. Key players such as Becton, Dickinson and Company and Smiths Medical dominate the market by offering a wide range of PIVC products that prioritize patient safety and ease of use. These companies invest heavily in research and development to create advanced catheters with integrated safety features that align with the growing demands of healthcare providers. Additionally, strategic partnerships and collaborations among manufacturers and healthcare providers are becoming increasingly common, allowing for a better understanding of market needs and accelerating the development of tailored solutions.

Terumo Corporation and Teleflex Incorporated are also prominent players in the PIVC market, leveraging their strong distribution networks and extensive product portfolios to capture significant market shares. These companies focus on enhancing product quality and patient outcomes by adopting advanced manufacturing processes and investing in innovative technologies, ensuring that they remain competitive in a rapidly evolving landscape. Furthermore, companies like Medtronic and 3M are exploring opportunities in emerging markets, capitalizing on the rising demand for intravenous therapies in regions with expanding healthcare infrastructure. By expanding their global presence, these players are positioning themselves for sustained growth in the PIVC market.

In summary, the Peripheral Intravenous Catheters (PIVC) market presents a dynamic environment, filled with opportunities for growth and innovation. With the increasing focus on patient safety and infection control, manufacturers must continue to adapt and evolve their product offerings to meet the changing needs of healthcare providers and patients alike. The strategic positioning of major companies, supported by continuous investment in technology and a commitment to quality, will play a crucial role in shaping the future of the PIVC market. As the landscape continues to evolve, maintaining a competitive edge will require agility, innovation, and a deep understanding of market dynamics and customer preferences.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Vygon S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Smiths Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 C.R. Bard, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fresenius Kabi AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 AngioDynamics, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Halyard Health, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Cardinal Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Teleflex Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Ruhof Healthcare, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Cook Medical Incorporated
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Nipro Medical Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Becton, Dickinson and Company
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Peripheral Intravenous Catheters PIVC Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Homecare Settings
    • 6.1.5 Others
  • 6.2 Peripheral Intravenous Catheters PIVC Sales Market, By Product Type
    • 6.2.1 Short PIVC
    • 6.2.2 Integrated PIVC
    • 6.2.3 Non-integrated PIVC
    • 6.2.4 Winged PIVC
    • 6.2.5 Ported PIVC
  • 6.3 Peripheral Intravenous Catheters PIVC Sales Market, By Material Type
    • 6.3.1 Polyurethane PIVC
    • 6.3.2 Teflon PIVC
    • 6.3.3 Polyethylene PIVC
    • 6.3.4 FEP PIVC
    • 6.3.5 Others
  • 6.4 Peripheral Intravenous Catheters PIVC Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Peripheral Intravenous Catheters PIVC Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Peripheral Intravenous Catheters PIVC Sales market is categorized based on

By Product Type

• Short PIVC
• Integrated PIVC
• Non-integrated PIVC
• Winged PIVC
• Ported PIVC

By Application

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By Material Type

• Polyurethane PIVC
• Teflon PIVC
• Polyethylene PIVC
• FEP PIVC
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Becton, Dickinson and Company
• Smiths Medical
• Vygon S.A.
• Teleflex Incorporated
• Terumo Corporation
• Fresenius Kabi AG
• Medtronic plc
• 3M Company
• Nipro Medical Corporation
• Cook Medical Incorporated
• AngioDynamics, Inc.
• Halyard Health, Inc.
• Cardinal Health, Inc.
• C.R. Bard, Inc.
• Ruhof Healthcare, Inc.